American Injectables Inc.

American Injectables Inc. specializes in the contract development and manufacturing of sterile injectable drugs, providing comprehensive solutions from formulation to patient-ready products for pharmaceutical and biopharmaceutical companies. American Injectables Inc. is engaged in the contract development and manufacturing of sterile injectable drugs.

The company is based in Tampa, US. In September 2020, American Injectables raised USD 10 mn in Series A funding from New Rhein Healthcare Investors, which will be utilized to increase production and launch new products. The CEO of the company is Adam Levitt. American Injectables specializes in the contract development and manufacturing of sterile injectable drugs, offering comprehensive end-to-end solutions from formulation to patient-ready product.

The company focuses on high-quality production of parenteral drugs in vials and syringes, with the capability to expand into cartridge formats. Their services cater to a diverse client base, including pharmaceutical and biopharmaceutical firms seeking reliable manufacturing partnerships. American Injectables operates in both U. S.

and global markets, providing solutions to clients across North America, Europe, and Asia, addressing various therapeutic needs in the healthcare sector. American Injectables generates revenue through its contract manufacturing services involving B2B transactions with pharmaceutical and biopharmaceutical companies. Clients engage with the company on a project basis, typically involving flexible batch sizes ranging from less than 1,000 to 150,000 units, depending on specific product requirements. The revenue model is structured around service agreements that include formulation development, process engineering, and stability testing.

Pricing structures reflect the complexity and customization of services provided, tailored to meet the individual needs of each client while ensuring safety and efficacy in the final injectable products. In September 2020, American Injectables Inc. raised USD 10 mn in Series A funding from New Rhein Healthcare Investors. The company plans to use this funding to increase its production capabilities and launch new products.

Their growth strategy includes expanding operations into new markets across North America and Europe, aiming for a broader geographical presence by 2023.